Avai BioAVAI -6.27%24 Market Cap is $20.74 Mil as of Jun. 29, 2026. GuruFocus rates AVAI with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 2,928 Software companies, Avai Bio ranks worse than 67.69% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Avai Bio's share price for the quarter that ended in Dec. 2025 was $0.38. Avai Bio's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 138.03 Mil. Therefore, Avai Bio's market cap for the quarter that ended in Dec. 2025 was $52.45 Mil.
Avai Bio's quarterly market cap
declined
from Jun. 2025 ($81.13 Mil) to Sep. 2025 ($44.52 Mil) but then
increased
from Sep. 2025 ($44.52 Mil) to Dec. 2025 ($52.45 Mil).
Avai Bio's annual market cap
increased
from Mar. 2023 ($57.76 Mil) to Mar. 2024 ($116.00 Mil) but then
declined
from Mar. 2024 ($116.00 Mil) to Mar. 2025 ($65.93 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Avai Bio's Enterprise Value for Today is $22.28 Mil.
Avai Bio (OTCPK:AVAI) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Avai Bio Market Cap Related Terms
Avai Bio Market Cap Historical Data
* Premium members only.
The historical data trend for Avai Bio's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Software - Application subindustry, Avai Bio's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avai Bio Market Cap vs Software Industry
For the Software industry and Technology sector, Avai Bio's Market Cap distribution charts can be found below:
* The bar in red indicates where Avai Bio's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Avai Bio's Market Cap for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avai Bio (AVAI) has a Market Cap of $20.74 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Avai Bio and its competitors. According to the industry distribution chart, Avai Bio ranks #1982 out of 2928 companies in the Software industry, placing it in the top 67.7%.
Is Avai Bio's Market Cap too high?
Avai Bio's current Market Cap is $20.74 Mil. The Software industry median Market Cap is 65.73. Avai Bio's value of $20.74 Mil is 68.4% below this industry median. Based on the distribution chart, Avai Bio ranks #1982 out of 2928 companies in the Software industry, which is below the industry midpoint. Overall, Avai Bio has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Avai Bio's Market Cap compare to IPM and RCT?
According to the Software industry distribution chart, Avai Bio ranks #1982 out of 2928 companies for Market Cap. This places Avai Bio in the lower half of its industry. The industry median Market Cap is 65.73. Avai Bio's value of $20.74 Mil is 68.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Software company?
The median Market Cap among Software companies is 65.73, based on 2,928 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avai Bio's current Market Cap of $20.74 Mil is 68.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Avai Bio and its competitors. For the Software industry, the median Market Cap is 65.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avai Bio's current Market Cap is $20.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avai Bio stock overvalued right now?
Avai Bio (AVAI) has a current Market Cap of $20.74 Mil. The current Market Cap is $20.74 Mil and 68.4% below the Software industry median of 65.73. Avai Bio's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Avai Bio (AVAI), the current Market Cap is $20.74 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Avai Bio Inc is a biotechnology company focused on identifying genetically modified cell lines, and through joint venture and licensing agreements, developing cell-based therapies. The company has two development programs in its cellular therapies pipeline, a diabetes development program to advance a treatment for type 1 and type 2 insulin-dependent diabetes, and an ?-Klotho protein development program to advance therapies for age-related diseases and anti-aging treatments.
24GF Score
Get the complete analysis for AVAI
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVAI has been successfully added to your 
